speb/financial-data huggingface dataset:
PHI1.DE balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 119000000.00
PHI1.DE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 14930310.00
PHI1.DE balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 14930310.00
PHI1.DE balance_sheet (annual, 2024-12-31) — Treasury Stock: 411000000.00
PHI1.DE balance_sheet (annual, 2024-12-31) — Work In Process: 414000000.00
PHI1.DE balance_sheet (quarterly, 2024-12-31) — Work In Process: 414000000.00
PHI1.DE balance_sheet (annual, 2024-12-31) — Working Capital: 1878000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — +Operating Expense: 1694000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — +Total Revenue: 4097000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1830000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3387000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6700000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 944671000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.08
PHI1.DE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2401000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -161000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -115000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 188000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1193000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1195000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -48000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -159000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -931000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Discontinued Operation: -10000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -165000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Inventory: -248000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -25000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -1066000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Payable: -165000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -165000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 160000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1344000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1148000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Common Stock: 188000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 11697000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2248000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1311000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Assets: 8669000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Debt: 513000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 513000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1771000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1771000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 6757000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Current Provisions: 874000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 27000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Deferred Tax: 27000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Depreciation: 276000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 276000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 276000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 3000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 957743000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.08
PHI1.DE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 76000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 8000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — EBIT: 186000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — EBITDA: 462000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -1000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 1000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -60000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — End Cash Position: 1193000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Financial Assets: 14000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -48000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 1577000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1094000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1489000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 161000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Goodwill: 10090000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 12977000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Gross Profit: 1849000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 48000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 42000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Interest Expense: 82000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 82000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Interest Income: 33000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 33000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -61000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 30000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Inventory: 3331000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19266000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -157000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 600000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 847000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 247000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 16000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 7056000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7056000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 9000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 247000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 988000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 31000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Minority Interests: 4000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -10000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Net Debt: 6376000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income: 76000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 76000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 78000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -6000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 76000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 82000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 78000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 72000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -46000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Interest Income: -49000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 10000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -47000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 9000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -49000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 2000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Net PPE: 2389000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 2000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -56000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -1280000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 218000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1916000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 491000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 412000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1916000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 79000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 462000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Normalized Income: 82000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -933000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Operating Income: 155000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Operating Revenue: 4097000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 925084000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 618000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 513000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 416000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 6000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Other Gand A: 161000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Other Income Expense: -1000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2887000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 92000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 137000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 30000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -11000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Payables: 1872000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3183000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Pretax Income: 104000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -10000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -46000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -17000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Receivables: 3477000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2248000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 276000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -63000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Research And Development: 457000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3728000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 27000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 2000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1087000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1248000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Share Issued: 940014310.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 7000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -63000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 48000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 11697000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1280000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Tax Provision: 27000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 90000000.00
PHI1.DE cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -86000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Assets: 27167000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 18753000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Debt: 7569000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11728000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Total Expenses: 3942000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 15439000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 18498000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 8682000000.00
PHI1.DE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 154000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 42000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 114000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 14930310.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 409000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Unrealized Gain Loss: -94000000.00
PHI1.DE balance_sheet (quarterly, 2025-03-31) — Working Capital: 1912000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — +Operating Expense: 1610000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — +Total Revenue: 4338000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1752000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3254000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7135000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 194000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 946332000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.25
PHI1.DE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1193000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -159000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -135000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1822000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1824000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -295000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 546000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -226000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 387000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -17000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Inventory: -120000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 18000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -73000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Payable: -17000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -17000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -33000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -225000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 708000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 193000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -295000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 10379000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2327000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1422000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 9063000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 1244000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1244000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1575000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1575000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7201000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Current Provisions: 758000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 95000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Deferred Tax: 95000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Depreciation: 266000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 266000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 266000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 7000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 956676000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.25
PHI1.DE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 240000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 3000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 33000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — EBIT: 417000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — EBITDA: 683000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -6000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 6000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -79000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — End Cash Position: 1822000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Financial Assets: 18000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 268000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 546000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 434000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 228000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 347000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 155000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 9363000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12075000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Gross Profit: 2011000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 99000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 58000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Interest Expense: 80000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 80000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Interest Income: 23000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 23000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -89000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 13000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Inventory: 3232000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 18805000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -225000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 462000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 686000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 224000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1019000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 7182000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7182000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1010000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 224000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 957000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 29000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Minority Interests: -1000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Net Debt: 6604000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income: 240000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 240000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 242000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -2000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 240000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 242000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 242000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 240000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -24000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Interest Income: -57000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -69000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 840000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 1010000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -57000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 1000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 2260000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 2000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -170000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1696000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 250000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1798000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 488000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 412000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1798000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 76000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 94000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 683000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Normalized Income: 242000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 387000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 7000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Operating Income: 401000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Operating Revenue: 4338000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 950574479.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 581000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1244000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 359000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 25000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -1000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Other Gand A: 155000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Other Income Expense: -6000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2712000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 78000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 135000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 26000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -31000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Payables: 1843000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3265000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Pretax Income: 337000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -24000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -80000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Receivables: 3327000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2327000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 266000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -179000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Research And Development: 402000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 3034000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 11000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 2000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1084000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1239000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 962920132.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 9000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -179000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 32000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 10379000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1696000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Tax Provision: 95000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 73000000.00
PHI1.DE cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -35000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 26379000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 17561000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 8426000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 10408000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Total Expenses: 3937000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 15971000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 17316000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 8770000000.00
PHI1.DE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 400000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 58000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 110000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 12345653.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 329000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Unrealized Gain Loss: -112000000.00
PHI1.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: 1862000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — +Operating Expense: 1581000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — +Total Revenue: 4302000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1713000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3271000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7168000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 112000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1822000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -158000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -135000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1912000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1912000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -33000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -68000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -158000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 327000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Discontinued Operation: 0.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -80000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -102000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 12000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -66000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Payable: -80000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -80000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -240000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 101000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Common Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10552000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 7000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2392000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1440000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Assets: 9278000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Debt: 1148000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1148000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1522000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1522000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 7030000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Current Provisions: 691000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 87000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 87000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Depreciation: 303000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 303000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 303000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 184000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 2000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — EBIT: 353000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — EBITDA: 656000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 2000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -1000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -11000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — End Cash Position: 1912000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -68000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 382000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 169000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 296000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 154000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Goodwill: 9341000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 11920000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Gross Profit: 1911000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 80000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 182000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Interest Expense: 78000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 78000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Interest Income: 21000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 21000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Interest Paid Cfo: -63000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 17000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Inventory: 3260000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 18937000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -158000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 619000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 765000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 146000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 7000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 22000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 7237000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 7237000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 22000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 146000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 956000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 31000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Minority Interests: -3000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 3000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 7000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Net Debt: 6473000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income: 184000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 184000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 188000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -1000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 184000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 185000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 188000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 187000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -23000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: -57000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -6000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -42000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 22000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -57000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 2219000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 3000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -64000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1368000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 213000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1798000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 492000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 415000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1798000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 77000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 656000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 185000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 327000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Operating Income: 330000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 4302000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 950979000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 593000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1148000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 334000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 30000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -1000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Other Gand A: 154000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Other Income Expense: 2000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2579000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 46000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 146000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 41000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -11000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Payables: 1895000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3335000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Pretax Income: 275000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -23000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -9000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Receivables: 3321000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2392000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 303000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -64000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Research And Development: 414000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3208000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 3000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 3000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1024000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1178000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 950979000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -64000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 32000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10552000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1368000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 87000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.32
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 50000000.00
PHI1.DE cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -43000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 26339000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17789000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 8385000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10583000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 3973000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 15756000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 17061000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 8726000000.00
PHI1.DE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 330000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 182000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 312000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Unrealized Gain Loss: -116000000.00
PHI1.DE balance_sheet (quarterly, 2025-09-30) — Working Capital: 2248000000.00
PHI1.DE income_statement (annual, 2025-12-31) — +Operating Expense: 6609000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — +Operating Expense: 1723000000.00
PHI1.DE income_statement (annual, 2025-12-31) — +Total Revenue: 17834000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 5098000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 1927000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1927000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3339000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3339000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3705000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3705000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7212000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7212000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -193000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -193000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 522000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 522000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 67000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 67000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 324000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 324000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 948239000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 951164000.00
PHI1.DE income_statement (annual, 2025-12-31) — Basic EPS: 0.94
PHI1.DE income_statement (quarterly, 2025-12-31) — Basic EPS: 0.42
PHI1.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2401000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1912000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -668000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -192000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -532000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -148000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 964000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 964000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 193000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2794000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2794000000.00